Latest filing published 08 Feb 2021 for Redwood Pharma AB, €3,468.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Hans Gunnar Ageland: trading record in brief
This profile gathers the share dealings of Hans Gunnar Ageland in Redwood Pharma AB. Between 23 April 2018 and 8 February 2021, the trades on record add up to 4 filings.
Both buying and selling appear: 3 purchases worth €13k, against 1 sale worth €164. The net balance comes to €13k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2021 alone, the filings show 1 purchase and no sales.
The median purchase comes to €3,468.
The latest filing, published on 8 February 2021, reports an open-market purchase of €3,468 in Redwood Pharma AB. The median gap between a trade and its publication by Finansinspektionen is 1 day. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Hans Gunnar Ageland
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ SEK 7.0026.6% of flowBTA (betald tecknad aktie)ISIN SE0015483185FI:csv-f4d0d4f43c6a88d5b1b0Canonical exit: 9 May 2021 (T+90)
- 3,000 shares@ SEK 7.2521.3% of flowBTA (betald tecknad aktie)ISIN SE0013102456FI:csv-2c47c893b76deead3e77Canonical exit: 22 Dec 2019 (T+90)
- 16,000 shares@ SEK 0.111.7% of flowTeckningsrättISIN SE0013102449FI:csv-06f2dcb8695b628d72ce
- 11,379 shares@ SEK 6.7577.0% of flowISIN SE0011088624FI:csv-d667656ae83d1ac9db33Canonical exit: 22 Jul 2018 (T+90)
4 of 4 declarations